Bilirubin and Redox Stress in Age-Related Brain Diseases

被引:16
作者
Llido, John Paul [1 ,2 ,3 ]
Jayanti, Sri [1 ,4 ]
Tiribelli, Claudio [1 ]
Gazzin, Silvia [1 ]
机构
[1] Italian Liver Fdn, Liver Brain Unit Rita Moretti, Bldg Q, AREA Sci Pk,Basovizza, I-34149 Trieste, Italy
[2] Philippine Council Hlth Res & Dev, Dept Sci & Technol, Taguig 1631, Philippines
[3] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy
[4] Natl Res & Innovat Agcy, Res Org Hlth, Eijkman Res Ctr Mol Biol, Cibinong 16911, Indonesia
关键词
Alzheimer's disease; dementia; sclerosis; schizophrenia; ataxia; therapy; brain cancers; NRF2; AHR; heme oxygenase; INDUCED OXIDATIVE STRESS; BILIVERDIN REDUCTASE; HEME OXYGENASE-1; SERUM BILIRUBIN; UNCONJUGATED BILIRUBIN; FLUORESCENT PROTEIN; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; ANTIOXIDANT STATUS;
D O I
10.3390/antiox12081525
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular redox status has a crucial role in brain physiology, as well as in pathologic conditions. Physiologic senescence, by dysregulating cellular redox homeostasis and decreasing antioxidant defenses, enhances the central nervous system's susceptibility to diseases. The reduction of free radical accumulation through lifestyle changes, and the supplementation of antioxidants as a prophylactic and therapeutic approach to increase brain health, are strongly suggested. Bilirubin is a powerful endogenous antioxidant, with more and more recognized roles as a biomarker of disease resistance, a predictor of all-cause mortality, and a molecule that may promote health in adults. The alteration of the expression and activity of the enzymes involved in bilirubin production, as well as an altered blood bilirubin level, are often reported in neurologic conditions and neurodegenerative diseases (together denoted NCDs) in aging. These changes may predict or contribute both positively and negatively to the diseases. Understanding the role of bilirubin in the onset and progression of NCDs will be functional to consider the benefits vs. the drawbacks and to hypothesize the best strategies for its manipulation for therapeutic purposes.
引用
收藏
页数:22
相关论文
共 229 条
[1]   Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments [J].
Alghamri, Mahmoud S. ;
McClellan, Brandon L. ;
Hartlage, Margaret S. ;
Haase, Santiago ;
Faisal, Syed Mohd ;
Thalla, Rohit ;
Dabaja, Ali ;
Banerjee, Kaushik ;
Carney, Stephen V. ;
Mujeeb, Anzar A. ;
Olin, Michael R. ;
Moon, James J. ;
Schwendeman, Anna ;
Lowenstein, Pedro R. ;
Castro, Maria G. .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[2]   Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives [J].
Alves, Ana Laura V. ;
Gomes, Izabela N. F. ;
Carloni, Adriana C. ;
Rosa, Marcela N. ;
da Silva, Luciane S. ;
Evangelista, Adriane F. ;
Reis, Rui Manuel ;
Silva, Viviane Aline O. .
STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
[3]   Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders [J].
Amin, Sanjiv B. ;
Smith, Tristram ;
Timler, Geralyn .
PEDIATRIC RESEARCH, 2019, 85 (02) :191-197
[4]   New Insights on the Nutrition Status and Antioxidant Capacity in Multiple Sclerosis Patients [J].
Armon-Omer, Ayelet ;
Waldman, Chen ;
Simaan, Naaem ;
Neuman, Hadar ;
Tamir, Snait ;
Shahien, Radi .
NUTRIENTS, 2019, 11 (02)
[5]  
Ashizawa Tetsuo, 2016, Continuum (Minneap Minn), V22, P1208, DOI 10.1212/CON.0000000000000362
[6]   Oxidant and anti-oxidant status in common brain tumors: Correlation to TP53 and human biliverdin reductase [J].
Atukeren, Pinar ;
Oner, Sena ;
Baran, Oguz ;
Kemerdere, Rahsan ;
Eren, Bulent ;
Cakatay, Ufuk ;
Tanriverdi, Taner .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 158 :72-76
[7]   Antioxidant status in neonatal jaundice before and after phototherapy [J].
Ayyappan, S. ;
Philip, Sachu ;
Bharathy, N. ;
Ramesh, V. ;
Kumar, C. Naveen ;
Swathi, S. ;
Kumar, A. Arun .
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2015, 7 (05) :S16-S21
[8]   Biliverdin reductase:: A major physiologic cytoprotectant [J].
Barañano, DE ;
Rao, M ;
Ferris, CD ;
Snyder, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) :16093-16098
[9]   The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation [J].
Barone, Eugenio ;
Di Domenico, Fabio ;
Mancuso, Cesare ;
Butterfield, D. Allan .
NEUROBIOLOGY OF DISEASE, 2014, 62 :144-159
[10]   Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease [J].
Barone, Eugenio ;
Mancuso, Cesare ;
Di Domenico, Fabio ;
Sultana, Rukhsana ;
Murphy, M. Paul ;
Head, Elizabeth ;
Butterfield, D. Allan .
JOURNAL OF NEUROCHEMISTRY, 2012, 120 (01) :135-146